Navigation Links
Lack of Evidence on Treatment for Narrowed Kidney Arteries

Increasing numbers of patients with narrowed kidney arteries are undergoing vessel-widening angioplasty and placement of a tubular stent//, but the latest scientific evidence does not show a clear advantage of that treatment over prescription drug therapy, according to a new review funded by the Agency for Healthcare Research and Quality. An article based on the review is posted today in the online version of the Annals of Internal Medicine.

Narrowed kidney arteries – a condition known as renal artery stenosis (RAS) – are the most common cause of correctable high blood pressure. The progressive condition reduces the supply of blood to the kidneys. In most cases the problem is caused by atherosclerosis, the gradual build-up of fat-containing plaque. RAS may occur alone or in combination with high blood pressure and chronic kidney disease. It is found in about 30 percent of patients with coronary artery disease and up to 50 percent of seniors or people who have diffuse atherosclerotic vascular diseases.

RAS patients have three treatment options: angioplasty, which reopens the narrowed artery with a small balloon; angioplasty in combination with a stent, a metal mesh tube placed inside the artery; or therapy with drugs, such as angiotensin converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs), calcium channel blockers, and/or beta blockers. Some doctors also recommend statins to lower cholesterol, or antiplatelet medicines, such as aspirin. Patients treated only with drugs, which may need to be taken for a lifetime, can experience diminished kidney function due to RAS. That can lead to sickness and death, and these patients may be at increased risk of heart disease. However, it is unclear whether angioplasty leads to better outcomes for most patients.

While many RAS patients are treated with drugs, a growing number of RAS patients are opting for angioplasty. Medicare data show that angioplasty more than doubled f
'"/>




Page: 1 2 3

Related medicine news :

1. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
2. Evidence supporting H.pylori eradication
3. Evidence against use of Beta blockers as first choice in the treatment of primary hypertension
4. Evidences that Better Health Care Facility is Offered By Public Hospitals.
5. First Conclusive Evidence Linking Oral Bacteria To Premature Babies
6. Study Provides Evidence That Obesity Leads To A More Aggressive Ovarian Cancer
7. No Clear Evidence for Ultra-Low Cholesterol Targets?
8. Some Evidence Shows Chinese Herbal Medicine Helps Angina Patients
9. Strong Evidence Suggests Incidence Of Mating Of Ancestors With Neanderthals
10. Dermatologists Provide Unique Evidence of Possible Cause of Rare Skin Condition
11. Is Evidence-based Medicine Enough to Support Additional Research in Alternative Medicine?
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Lack Evidence Treatment for Narrowed Kidney Arteries

(Date:8/1/2015)... (PRWEB) , ... August 01, 2015 , ... ... Partners I, L.P. (“GPP”) portfolio company has acquired Premier Physical Therapy & Wellness ... into its portfolio of state-of-the-art clinics. , “Our acquisition of Premier Physical Therapy ...
(Date:8/1/2015)... ... August 01, 2015 , ... Lume Wellness creators Alex, Robert, and Sam have ... the Apple AppStore. , The app is designed to track various metrics of ... tool to view personal health and use this information for positive behavior modification. Lume ...
(Date:8/1/2015)... ... ... “ reTXT ” was featured on NewsWatch as part of its monthly AppWatch, ... iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted ... any message including ones already sent. , While text messaging has more features than ...
(Date:7/31/2015)... ... 31, 2015 , ... That’s right, the STASH awards have ... The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, featured in High ... that have stood the test of time. These include lighting products, organic and ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... When the ... stuff, Super-Sod debuted their new type of sod called Leisure Time(TM) zoysia . ... in process. , To commemorate introduction of this new type of sod, Super-Sod is ...
Breaking Medicine News(10 mins):Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2
... An emerging body of scientific research about probiotics ... Nutrients, Are They Here To Stay?" an annual ... Symposium. Every year, cutting-edge topics are selected to provide ... leaders and healthcare providers, and this year probiotics took ...
... can make all the difference in controlling it. Who ... When should counties and states shut down airports, schools, and highways? ... and work? As America and the world braces ... it may have a solution that can save both time and ...
... UCI Medical Affiliates, Inc. (UCIA.PK) announced that on ... a Complaint in the United States District Court for ... Jr., the former Executive Vice-President of Finance, Chief Financial ... "Company"), alleging violations of the Securities and Exchange Act ...
... Can Be Brought Into Service , , OTTAWA, ... of medical isotopes and radiopharmaceuticals, today continued to urge ... Limited (AECL) to complete the MAPLE project to address ... earlier today by AECL that the 52-year-old National Research ...
... is a statement of Matthew L. Myers, President, Campaign for ... ) , , We urge North Carolina legislators to ... North Carolina families by heeding Governor Bev Perdue,s call to ... While a larger cigarette tax increase would produce even greater ...
... Elsevier, a world-leading publisher of scientific, technical and medical ... PM&R -The journal of injury, function and ... the American Academy of Physical Medicine and Rehabilitation (AAPM&R), ... months after its launch in January 2009. Under ...
Cached Medicine News:Health News:Harvard Medical School Continues Education About Benefits of Probiotics 2Health News:Harvard Medical School Continues Education About Benefits of Probiotics 3Health News:Harvard Medical School Continues Education About Benefits of Probiotics 4Health News:Fighting the swine flu pandemic with mathematics 2Health News:UCI Medical Affiliates, Inc.'s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 2Health News:UCI Medical Affiliates, Inc.'s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 3Health News:UCI Medical Affiliates, Inc.'s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 4Health News:MDS Nordion Continues to Urge Government of Canada to Complete MAPLE Project to Address Critical Medical Isotope Shortage 2Health News:MDS Nordion Continues to Urge Government of Canada to Complete MAPLE Project to Address Critical Medical Isotope Shortage 3Health News:MDS Nordion Continues to Urge Government of Canada to Complete MAPLE Project to Address Critical Medical Isotope Shortage 4Health News:North Carolina Should Increase Cigarette Tax by 50 Cents to Save Lives and Raise Revenue 2Health News:North Carolina Should Increase Cigarette Tax by 50 Cents to Save Lives and Raise Revenue 3Health News:PM&R accepted for abstracting and indexing in MEDLINE 2
(Date:7/30/2015)... CHENGDU, China , July 30, 2015 ... "Company"), a pharmaceutical company that specializes in the patented ... active pharmaceutical ingredients (API), provided updates regarding the notice ... MKT LLC (the "Exchange") indicating that the Company was ... set forth in Sections 134 and 1101 of the ...
(Date:7/30/2015)... , July 30, 2015 Eisai Inc. announced ... the United States , European Union and ... and MHLW, respectively) for eribulin, for the treatment of ... received prior chemotherapy for advanced or metastatic disease. ... from a pivotal global Phase 3 clinical trial (Study ...
(Date:7/30/2015)... , July 30, 2015 ... latest report titled, "Continuous Glucose Monitoring Systems Market: Global ... to the report, the global continuous glucose monitoring systems ... and is expected to reach US$ 788.4 Mn by ... period, 2015 to 2020. Global continuous glucose ...
Breaking Medicine Technology:TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
... Reports Significantly More Patients Treated,with Taxotere(R)-Based ... CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- ... maintained long-term efficacy as a treatment ... to the three-year updated results of ...
... - Schering-Plough Corp. announced results,from a Phase ... (pegylated liposomal doxorubicin hydrochloride),significantly prolonged time to ... with infrequent and manageable clinical,toxicity after first-line ... 43rd Annual Meeting of the American Society ...
Cached Medicine Technology:Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 2Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 3Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 4Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 2Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 3Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 4Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 5
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: